SCHEMBL20042929

SCHEMBL20042929

Cc1nc2c(c(N3CCC3)n1)C(C)N(C(=O)c1cccc(Cl)c1)C2C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
TACR2 P21452 1/20 0.42
TACR3 P29371 1/20 0.42
KCNH2 Q12809 1/20 0.42
PKM P14618 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 5/20 0.40
TP53 P04637 1/20 0.39
THRB P10828 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
PGR P06401 1/20 0.39
MGLL Q99685 1/20 0.39
MEN1 O00255 1/20 0.39
HSP90AA1 P07900 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042892 0.87 HSD17B10 (0.44) LMNATACR3KCNH2CYP2D6CYP2C19
SCHEMBL20042841 0.81 TACR2 (0.45) LMNATACR2TACR3KCNH2PKM
SCHEMBL20042771 0.73 P2RX7 (0.47) LMNAPKMALDH1A1L3MBTL1KDM4E
SCHEMBL20042922 0.73 TACR2 (0.40) LMNATACR2TACR3KCNH2PKM
SCHEMBL20042927 0.71 TACR2 (0.40) LMNATACR2TACR3KCNH2PKM
SCHEMBL20042898 0.69 TACR3 (0.45) LMNATACR3KCNH2CYP2D6CYP2C19
SCHEMBL20042851 0.67 P2RX7 (0.46) LMNATACR2TACR3KCNH2CYP2D6
SCHEMBL20042982 0.67 P2RX7 (0.46) LMNATACR2TACR3KCNH2CYP2D6
SCHEMBL20042798 0.67 TACR3 (0.42) LMNATACR2TACR3KCNH2CYP2D6
SCHEMBL20042878 0.67 TACR3 (0.47) TACR2TACR3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed